Device General - Io Ablation_pi

General - Io Ablation

Payments companies reported to CMS as associated with General - Io Ablation. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$259Kassociated payments (2023-2025)
74clinicians with associated payments
1company reporting

By year

2025 $259K

Payments reported as associated with General - Io Ablation, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $173K
Diagnostic Radiology $73K
Medical Oncology $8,337
Surgery $5,019
Physician Assistant $86.32
Gerontology (Nurse Practitioner) $80.56

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with General - Io Ablation

These are the largest totals companies reported as associated with General - Io Ablation. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Aron Chary Germantown, TN Vascular & Interventional Radiology $39,532.87
Rahul Sheth Houston, TX Vascular & Interventional Radiology $33,422.68
Neil Resnick Worcester, MA Vascular & Interventional Radiology $22,587.16
Shamar Young Tucson, AZ Vascular & Interventional Radiology $19,002.29
Scott Genshaft Los Angeles, CA Diagnostic Radiology $18,570.50
Jennifer Buckley Kansas City, MO Diagnostic Radiology $13,060.23
Vijay Ramalingam Boston, MA Diagnostic Radiology $11,789.14
Alexa Levey New Haven, CT Vascular & Interventional Radiology $10,500.00
Anthony Tadros San Diego, CA Vascular & Interventional Radiology $9,594.21
Florian Fintelmann Boston, MA Diagnostic Radiology $9,450.00

Prescribed General - Io Ablation?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.